REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model
Psoriasis is a chronic inflammatory skin disease characterized by epidermal hyperplasia and cellular infiltration. Studies have shown that disease development depends on proinflammatory cytokines, such as interleukin (IL)-23 and IL-17. It has been suggested that IL-23 produced by innate immune cells...
Main Authors: | Shangyi Wang, Mina Kozai, Hironobu Mita, Zimeng Cai, Md. Abdul Masum, Osamu Ichii, Kensuke Takada, Mutsumi Inaba |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221010672 |
Similar Items
-
Chronopharmacological targeting of Rev-erbα by puerarin alleviates hyperhomocysteinemia in mice
by: Min Chen, et al.
Published: (2020-05-01) -
Rôle du récepteur nucléaire Rev-erb-α dans la fonction du réticulum sarcoplasmique du muscle squelettique : implications physiologiques et pathologiques
by: Boulinguiez, Alexis
Published: (2019) -
Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
by: Qingxue Liu, et al.
Published: (2021-07-01) -
Rev-erbα Inhibits Proliferation and Promotes Apoptosis of Preadipocytes through the Agonist GSK4112
by: Guiyan Chu, et al.
Published: (2019-09-01) -
Translational Regulation of Clock Genes BMAL1 and REV-ERBα by Polyamines
by: Akihiko Sakamoto, et al.
Published: (2021-01-01)